Raquel Del Campo
Palma, PM, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Real-world resource utilization, toxicity management, and efficacy outcomes of CD20 × CD3 bispecific antibodies in B-cell lymphoma: A study from the GELTAMO network.
Journal: HemaSphere
Published: December 11, 2025
Laboratory Prognostic Index (LAB-PI) in diffuse large B-cell lymphoma: a single blood analysis predicts outcomes as good as IPI, NCCN-IPI, and GELTAMO-IPI.
Journal: ESMO open
Published: February 05, 2025
Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study.
Journal: Cancers
Published: January 21, 2024
Total Lesion Glycolysis Improves Tumor Burden Evaluation and Risk Assessment at Diagnosis in Hodgkin Lymphoma.
Journal: Journal of clinical medicine
Published: August 19, 2021
Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real-world study.
Journal: Cancer medicine
Published: May 07, 2021
Prognostic Role of the Red Blood Cell Distribution Width (RDW) in Hodgkin Lymphoma.
Journal: Cancers
Published: September 27, 2020
RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group.
Journal: Annals of hematology
Published: September 08, 2019
New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta-2 microglobulin in patients with diffuse large B-cell lymphoma treated with R-CHOP: Spanish Lymphoma Group Experience (GELTAMO).
Journal: British journal of haematology
Published: September 02, 2019
Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group.
Journal: British journal of haematology
Published: July 01, 2018
Last Updated: 09/26/2026